Federated Hermes, Inc. Ideaya Biosciences, Inc. Transaction History

Federated Hermes, Inc.

  • $43.9 Billion
  • Q1 2025

A detailed history of Federated Hermes, Inc. transactions in Ideaya Biosciences, Inc. stock. As of the latest transaction made, Federated Hermes, Inc. holds 4,767,926 shares of IDYA stock, worth $101 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares
4,767,926
Previous 5,063,526 5.84%
Holding current value
$101 Million
Previous $130 Million 39.99%
% of portfolio
0.18%
Previous 0.3%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 08, 2025
SELL
$16.38 - $26.0 $4.84 Million - $7.69 Million
-295,600 Reduced 5.84%
4,767,926 $78.1 Million
Q4 2024

Feb 13, 2025
SELL
$24.79 - $31.98 $3.59 Million - $4.63 Million
-144,774 Reduced 2.78%
5,063,526 $130 Million
Q3 2024

Nov 13, 2024
BUY
$30.37 - $43.05 $10.7 Million - $15.2 Million
352,510 Added 7.26%
5,208,300 $165 Million
Q2 2024

Aug 08, 2024
SELL
$34.37 - $43.46 $9,898 - $12,516
-288 Reduced 0.01%
4,855,790 $170 Million
Q1 2024

May 14, 2024
BUY
$34.2 - $47.13 $33.3 Million - $45.8 Million
972,303 Added 25.03%
4,856,078 $213 Million
Q4 2023

Jan 31, 2024
BUY
$24.59 - $35.83 $12.3 Million - $17.9 Million
500,046 Added 14.78%
3,883,775 $138 Million
Q3 2023

Nov 13, 2023
SELL
$21.07 - $29.77 $125,766 - $177,697
-5,969 Reduced 0.18%
3,383,729 $91.3 Million
Q2 2023

Aug 14, 2023
BUY
$13.33 - $25.53 $7 Million - $13.4 Million
525,091 Added 18.33%
3,389,698 $79.7 Million
Q1 2023

May 08, 2023
BUY
$13.49 - $18.72 $1,443 - $2,003
107 Added 0.0%
2,864,607 $39.3 Million
Q4 2022

Feb 13, 2023
BUY
$14.47 - $18.17 $34,858 - $43,771
2,409 Added 0.08%
2,864,500 $52 Million
Q3 2022

Nov 14, 2022
BUY
$9.24 - $15.79 $6.47 Million - $11.1 Million
700,000 Added 32.38%
2,862,091 $42.7 Million
Q2 2022

Aug 15, 2022
SELL
$8.28 - $13.88 $721,096 - $1.21 Million
-87,089 Reduced 3.87%
2,162,091 $29.8 Million
Q1 2022

May 13, 2022
SELL
$11.18 - $24.02 $459,520 - $987,270
-41,102 Reduced 1.79%
2,249,180 $25.2 Million
Q4 2021

Feb 14, 2022
SELL
$20.95 - $26.88 $312,029 - $400,350
-14,894 Reduced 0.65%
2,290,282 $54.1 Million
Q3 2021

Nov 15, 2021
BUY
$17.26 - $27.08 $11.5 Million - $18.1 Million
668,237 Added 40.82%
2,305,176 $58.8 Million
Q2 2021

Aug 16, 2021
BUY
$17.76 - $24.83 $2.32 Million - $3.25 Million
130,727 Added 8.68%
1,636,939 $34.4 Million
Q1 2021

May 13, 2021
BUY
$13.48 - $23.77 $5.5 Million - $9.69 Million
407,864 Added 37.13%
1,506,212 $35.4 Million
Q4 2020

Feb 12, 2021
BUY
$12.17 - $17.52 $13.4 Million - $19.2 Million
1,097,266 Added 101410.91%
1,098,348 $15.4 Million
Q3 2020

Nov 12, 2020
BUY
$11.22 - $14.46 $12,140 - $15,645
1,082 New
1,082 $14,000

Others Institutions Holding IDYA

# of Institutions
212
Shares Held
80.3M
Call Options Held
80.3K
Put Options Held
30.5K
View Full List

About IDEAYA Biosciences, Inc.

IDYA Quotes by TradingView
  • Ticker IDYA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,067,700
  • Market Cap $1.01B
  • Description
  • IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...
More about IDYA
Track This Portfolio

Track Federated Hermes, Inc. Portfolio

Follow Federated Hermes, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email